Results 81 to 90 of about 22,089 (224)
Primers used to amplify VP1 and 3Dpol regions of the Coxsackievirus B1.
, 2015 a Numbering system used in the Coxsackievirus B1 strain (Accession No. M16560).Primers used to amplify VP1 and 3Dpol regions of the Coxsackievirus B1.
Bintou Sanno-Duanda (751478) +13 more
core +1 more source
Epidemics of enterovirus infection in Chungnam Korea, 2008 and 2009
Virology Journal, 2011 Previously, we explored the epidemic pattern and molecular characterization of enteroviruses isolated in Chungnam, Korea from 2005 to 2006. The present study extended these observations to 2008 and 2009.
Hwang SeoYeon +11 more
doaj +1 more source
Imaging-Based Reporter Systems to Define CVB-Induced Membrane Remodeling in Living Cells
Viruses, 2020 Enteroviruses manipulate host membranes to form replication organelles, which concentrate viral and host factors to allow for efficient replication. However, this process has not been well-studied in living cells throughout the course of infection.
Nicholas J. Lennemann +2 more
doaj +1 more source
Regulation of Immune Checkpoints: From Molecular Mechanisms to Clinical Therapies
MedComm, Volume 7, Issue 6, June 2026.Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by unleashing antitumor immunity. This review comprehensively examines the molecular mechanisms underlying key immune checkpoints—including PD‐1/PD‐L1, CTLA‐4, and TIM‐3—and their clinical applications.
Qintao Ge +9 more
wiley +1 more source
Peculiar Clinical Presentation of Coxsackievirus B4 Infection: Neonatal Restrictive Cardiomyopathy
, 2017 Introduction Restrictive cardiomyopathy in fetuses and neonates is extremely rare and has a poor outcome. Its etiology in neonates is elusive: metabolic diseases (e.g., Gaucher, Hurler syndrome), neuromuscular disorders (e.g., muscular ...
Desprez, Philippe +13 more
core +1 more source
Quinoxaline derivatives as new inhibitors of coxsackievirus B5 [PDF]
, 2018 Enteroviruses are among the most common and important human pathogens for which there are no specific antiviral agents approved by the US Food and Drug Administration so far.
Laurini E. +14 more
core +2 more sources
Trends in the enterovirus surveillance in Oslo, Norway before and during the COVID-19 pandemic
Frontiers in VirologyBackgroundEnteroviruses have the potential to cause both high morbidity and mortality especially in children. High season in Norway is between August and November, but this seasonality was interrupted by the COVID-19 pandemic.MethodsIn this study, we ...
Susanne Dudman +10 more
doaj +1 more source
Inflammation, Immunity, and Cardiovascular Diseases
Med Research, Volume 2, Issue 2, Page 343-370, June 2026.Cardiovascular stress signals (e.g., hemodynamic shear, oxidized lipids, and ischemia) act on endothelial and immune cells to activate and amplify inflammation through NF‐κB, the NLRP3 inflammasome, and JAK/STAT signaling, inducing proinflammatory cytokines/chemokines (IL‐6, IL‐1β, TNF‐α, and CCL2) and self‐amplifying circuits; clinically, inflammatory
Dezhi Guo +8 more
wiley +1 more source
Microbiota Medicine Research, Volume 1, Issue 2, Page 63-89, June 2026.ABSTRACT The growing recognition of the microbiome’s role in human health has propelled the emergence of microbiota medicine—a new discipline integrating microbiology, multi‐omics, and clinical science. Advances in sequencing, data integration, and interventions such as fecal microbiota transplantation (FMT) have transitioned the field from ...
Min Dai +6 more
wiley +1 more source